HeartSciences (HSCS) Volume Jumps 3.4x on Fortitude Merger Plan
HeartSciences (HSCS) volume surged to 3.4x average after a proxy filing for a merger with crypto miner Fortitude, even as debt levels near 2,228% and EPS missed by -16.8%.
signal:HSCS:2026-08-19 HeartSciences (HSCS) Volume Jumps 3.4x on Fortitude Merger Plan
On July 29, HeartSciences (HSCS) filed a preliminary proxy statement for a proposed business combination with Fortitude Mining Holdings, a Zcash mining operator, alongside its fiscal 2026 financial results — a dual catalyst that drove trading volume to 3.4x its 20-day average as the market scrambled to reprice the company's future direction.
The volume spike signals that investors are actively debating whether HSCS's identity shifts from an AI-enhanced ECG technology developer toward a stake in a crypto-mining infrastructure business, which is precisely why the stock has landed on the radar even as its underlying medtech fundamentals remain under pressure.
Key Facts
| Stock name | HSCS |
|---|---|
| Ticker | HSCS |
| Market | NASDAQ |
| Sector | Unclassified |
| Volume (x average) | 3.4x |
| Signal price | $2.55 |
HeartSciences Inc., formerly known as Heart Test Laboratories, is a medical technology company based in Southlake, Texas, that develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions. Its flagship MyoVista wavECG device is a resting 12-lead ECG system designed to detect impaired cardiac relaxation and other signs of cardiac dysfunction, while its MyoVista Insights platform offers cloud-native, vendor-agnostic ECG data management for clinicians.
Recent Analyst Coverage
External analyst opinions (not investment advice): (2026-08-01)
| Strong Buy | 2 |
|---|---|
| Buy | 5 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
Peer Companies
ADGM, IRIX, SINT, CVB.AX, SCND
Risk Factors
The proposed combination with Fortitude Mining Holdings is still at the preliminary proxy stage, meaning shareholder and regulatory approval, deal terms, and potential dilution remain unresolved — a pivot of this magnitude, from ECG diagnostics to crypto-mining infrastructure, introduces execution and strategic-direction uncertainty that is specific to this situation rather than the broader unclassified-industry backdrop.
The balance sheet also warrants scrutiny: a debt ratio of roughly 2,228% and ROE of -4,055.1% point to a fragile capital structure, EV/EBITDA sits at -1.3x on negative earnings, and the most recent quarter (2026-06-30) missed EPS estimates by -16.8% (-0.87 actual vs. -0.7446 expected), underscoring persistent cash-burn risk heading into any merger integration.
On the macro side, the VIX at 14.9 reflects a calm volatility regime and the US high-yield credit spread (OAS) is flat at 2.75 percentage points, so systemic risk appetite is not currently a headwind. However, the dollar index has fallen 2.3% over the past month, a shift that can add currency-driven volatility for small, thinly-traded names like HSCS even as broad risk sentiment stays subdued.
Recent Disclosures
Recent News
- 2026-07-29 HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
- 2026-07-28 Zcash Miner Fortitude Powers Up Nebraska Facility as It Eyes Public Listing
- 2026-07-28 Fortitude Energizes 12 MW Grand Island, Nebraska Facility, Expanding Owned-and-Operated Power Portfolio
Earnings Trend
| Fiscal Year | Revenue | Net Income |
|---|---|---|
| 2024 | $0M | $-7M |
| 2025 | $0M | $-9M |
| 2026 | $0M | $-9M |
Pre-Trade Checklist
| Business & competitive edge understood | ✅ Company profile summarized above |
|---|---|
| Leading sector | ⚠️ Not flagged as a leading sector |
| Good news already priced in? | ⚠️ Insufficient valuation data to judge |
| Stop-loss / take-profit set | ✅ Stop-loss -10% / first take-profit +20% set in advance |
| Exit plan if wrong | ✅ 10% trailing stop from peak; setup auto-invalidated on a break below key support |
Trade Levels
| Signal price | $2.55 |
|---|---|
| Stop-loss | $2.29 (-10% from signal price) |
| First take-profit | $3.05 (+20% from signal price) |
| Trailing stop | 10% from peak |
| Invalidation | Close back below key support ($2.33) |
With shares trading near the $2.55 signal price, this is a name to keep on the watchlist rather than act on immediately: a move toward the $3.05 target (+20%) would need to hold above the $2.33 support level to preserve the setup's thesis, while a break below the $2.29 stop-loss (-10%) would invalidate it — the merger review process and next earnings update are the key events to monitor from here.